Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Guolian Securities Co., Ltd. Class H ( (HK:1456) ).
Guolian Minsheng Investment Banking Company Limited, a wholly owned subsidiary of Guolian Minsheng Securities Company Limited, has lodged an appeal to the Shandong High People’s Court against a first‑instance ruling that held it jointly and severally liable, up to 5% of the amount, for investor losses linked to alleged securities misrepresentation involving Shandong Longlive Bio-Technology Co., Ltd. The firm is seeking to overturn the Jinan Intermediate People’s Court judgment and have all 1,618 investor claims against it dismissed, arguing that its conduct does not meet the legal requirements for tort liability in securities misrepresentation cases, a move that could significantly affect its potential compensation exposure and clarify its legal responsibilities within China’s tightening securities enforcement landscape.
The most recent analyst rating on (HK:1456) stock is a Hold with a HK$6.00 price target. To see the full list of analyst forecasts on Guolian Securities Co., Ltd. Class H stock, see the HK:1456 Stock Forecast page.
More about Guolian Securities Co., Ltd. Class H
Guolian Securities Co., Ltd. Class H, through its wholly owned subsidiary Guolian Minsheng Securities Company Limited and its unit Guolian Minsheng Investment Banking Company Limited, operates in the securities industry in China, focusing on investment banking services such as underwriting and sponsorship for capital markets transactions.
Average Trading Volume: 4,131,385
Technical Sentiment Signal: Buy
Current Market Cap: HK$60.82B
Learn more about 1456 stock on TipRanks’ Stock Analysis page.